Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study.

Livia FaesAmit V MishraVeronika LipkovaKonstantinos BalaskasChrystie Wan Ning QuekRobin HamiltonUlrike HeldDawn SimSobha SivaprasadDun Jack Fu

Published in: Journal of clinical medicine (2023)

Most patients can be expected to have a positive visual outcome following an initial injection of dexamethasone implants that subsides within 4 months. Real-world re-treatment was observed to be delayed until after visual benefits were lost in half of the cohort. Further research will be needed to study the effects of delays in re-treatment.

Keyphrases

end stage renal disease
high dose
chronic kidney disease
newly diagnosed
type diabetes
metabolic syndrome
combination therapy
vascular endothelial growth factor
diabetic retinopathy
patient reported outcomes
optical coherence tomography
glycemic control